Editas Medicine EDIT reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Editas Medicine beat estimated earnings by 6.33%, reporting an EPS of $-0.74 versus an estimate of $-0.79.
Revenue was up $272.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11 which was followed by a 6.56% increase in the share price the next day.
Here's a look at Editas Medicine's past performance:
|Quarter||Q4 2021||Q3 2021||Q2 2021||Q1 2021|
To track all earnings releases for Editas Medicine visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.